Literature DB >> 23920697

Overrides of clinical decision support alerts in primary care clinics.

Sarah P Slight1, Karen C Nanji, Diane L Seger, Insook Cho, Lynn A Volk, David W Bates.   

Abstract

Clinical Decision Support (CDS) systems can alert physicians about potential clinical risks and suggest suitable treatment alternatives at appropriate times in the health care process. We evaluated the frequency with which physicians overrode medication alerts and the override reasons provided. Data obtained from primary care practices affiliated with two Harvard teaching hospitals were downloaded. Physicians overrode more than half of CDS medication alerts, with formulary, age-based, and renal substitutions the most likely. Many drug-drug and drug-allergy interactions overridden had the potential to cause patient harm.

Entities:  

Mesh:

Year:  2013        PMID: 23920697

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  4 in total

1.  Electronic pharmacopoeia: a missed opportunity for safe opioid prescribing information?

Authors:  Jeff Lapoint; Jeanmarie Perrone; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2014-03

2.  Potential drug-related problems detected by electronic expert support system: physicians' views on clinical relevance.

Authors:  Tora Hammar; Bodil Lidström; Göran Petersson; Yngve Gustafson; Birgit Eiermann
Journal:  Int J Clin Pharm       Date:  2015-06-06

3.  Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events.

Authors:  Christian Skalafouris; Jean-Luc Reny; Jérôme Stirnemann; Olivier Grosgurin; François Eggimann; Damien Grauser; Daniel Teixeira; Megane Jermini; Christel Bruggmann; Pascal Bonnabry; Bertrand Guignard
Journal:  BMC Med Inform Decis Mak       Date:  2022-05-31       Impact factor: 3.298

4.  Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study.

Authors:  Amandeep Khatter; Frank Moriarty; Mark Ashworth; Stevo Durbaba; Patrick Redmond
Journal:  Br J Gen Pract       Date:  2021-06-24       Impact factor: 6.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.